Prelude Therapeutics
PRLD
#9185
Rank
C$0.10 B
Marketcap
$1.87
Share price
46.40%
Change (1 day)
-66.53%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$2.93

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.12. In 2022 the company made an earnings per share (EPS) of -$3.51 a decrease over its 2021 EPS that were of -$3.48.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.93-16.55%
2022-$3.510.83%
2021-$3.48-61.3%
2020-$8.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.13 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA